Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;24(4):239-45.
doi: 10.3727/096504016X14648701448011.

Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma

Affiliations

Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma

Xin-Sheng Cheng et al. Oncol Res. 2016.

Abstract

Our aim was to study the expression of human SET domain containing protein 1A (hSETD1A) in hepatocellular carcinoma patients and its relationship with human hepatocellular carcinoma cell function. A total of 30 patients with hepatocellular carcinoma were enrolled in this study. The expression of hSETD1A was detected by real-time polymerase chain reaction (PCR) and Western blotting. The immortalized normal human liver cell line including SMMC-7721 was subjected to real-time PCR for hSETD1A mRNA. Furthermore, hSETD1A-small hairpin RNA (shRNA) was used to knock down hSETD1A expression in SMMC-7721 cells. Cell proliferation, cell apoptosis, and cell migration were determined by CCK8, flow cytometry, and Transwell assays. The positive expression rate level of hSETD1A mRNA and protein in liver carcinoma tissues was 73.33%. hSETD1A knockdown using a specific hSETD1A-shRNA inhibited cell proliferation and promoted cell apoptosis in SMMC-7721 cells. It was also found that downregulation of hSETD1A inhibited cell migration ability but did not affect cell invasion. In conclusion, the expression of hSETD1A occurs at a high rate in hepatocellular carcinoma patients. The expression state of hSETD1A may be a prognostic factor in hepatocellular carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Expression of human SET domain containing protein 1A (hSETD1A) in liver carcinoma tissue (C), adjacent normal tissue (N), respectively, of HCC patients as detected by real-time polymerase chain reaction (PCR) (A) and Western blotting (B). **p < 0.01.
Figure 2
Figure 2
Expression of hSETD1A in SMCC-7721, LM3, Hep3B, huh7, and HepG2 as detected by real-time PCR. *p < 0.05; **p < 0.01.
Figure 3
Figure 3
Downregulation of hSETD1A promotes growth of SMCC-7721 cells in vitro. (A) Expression of hSETD1A in SMCC-7721 after downregulation of hSETD1A. (B) Cell numbers were counted in the following time points: 24, 48, 72, and 96 h. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 4
Figure 4
Induction of apoptosis change. (A) SMMC-7721 cells were transfected with small hairpin RNAs (shRNAs) for 72 h before being harvested for apoptosis test. (B) Percentage of SMMC-7721 cell apoptosis in the 72-h time point. ***p < 0.001.
Figure 5
Figure 5
Suppressive effect of shRNA-mediated hSETD1A silencing on the migration potential of SMMC-7721 cells. (A) Migration tests. (B) Percentage of SMMC-7721 cell migration in the 24-h time point. **p < 0.01.

Similar articles

Cited by

References

    1. Bosetti C.; Turati F.; La Vecchia C. Hepatocellular carcinoma epidemiology. Best. Pract. Res. Clin. Gastroenterol. 28:753–770; 2014. - PubMed
    1. Xu J.; Li J.; Chen J.; Liu Z. J. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy-meta-analysis. Adv. Clin. Exp. Med. 24:331–340; 2015. - PubMed
    1. Chang Q.; Zhang Y.; Beezhold K. J.; Bhatia D.; Zhao H.; Chen J.; Castranova V.; Shi X.; Chen F. Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. J. Hepatol. 50:323–333; 2009. - PMC - PubMed
    1. Ting C. T.; Li W. C.; Chen C. Y.; Tsai T. H. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma. J. Chin. Med. Assoc. 78:139–144; 2015. - PubMed
    1. Alsinet C.; Villanueva A. Genomic prognostic markers in hepatocellular carcinoma. Gastroenterol. Hepatol. 35:94–101; 2012. - PubMed

Substances

LinkOut - more resources